# The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)

> **NCT03120299** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 309 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Hypertriglyceridemia

## Interventions

- **DRUG:** Omega-3 fatty acid
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03120299
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03120299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03120299, "The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03120299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
